In a combination protocol, some researchers theorize that starting at a lower dose (1mg daily) and assessing tolerance before escalating to the full 2mg might reduce the risk of compounding side effects with retatrutide
When retatrutide launches, you'll be ready to access it quickly rather than spending months navigating insurance barriers while paying full price
The STEP trials for semaglutide and the SURMOUNT trials for tirzepatide both measured outcomes over 6872 weeks, and researchers have documented significant weight regain in patients who discontinue treatment prematurely
Slow or stalled weight loss after two months warrants evaluation for medication adherence, injection technique, lifestyle factors, and genetic response patterns
Administration of the horomone leptin to obese animals produced weight loss by decreasing appetite while at the same time increasing the rate of fat metabolism
Our study found that patients using semaglutide 1 mg have a higher risk of depression, anxiety, and suicidal ideation when compared with non-semaglutide users, irrespective of age and sex differences